Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CARE RATING 2020-21 Annual Report Analysis
Wed, 31 Mar

CARE RATING has announced its results for the year ended March 2021. Let us have a look at the detailed performance review of the company during FY20-21.

CARE RATING Income Statement Analysis

  • Operating income during the year rose 2.0% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 17.8% YoY during the fiscal. Operating profit margins witnessed a fall and down at 38.5% in FY21 as against 33.4% in FY20.
  • Depreciation charges increased by 0.4% and finance costs decreased by 33.4% YoY, respectively.
  • Other income declined by 0.6% YoY.
  • Net profit for the year grew by 9.0% YoY.
  • Net profit margins during the year grew from 34.3% in FY20 to 36.6% in FY21.

CARE RATING Income Statement 2020-21

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Net Sales Rs m 2,436 2,484 2.0%
Other income Rs m 315 313 -0.6%
Total Revenues Rs m 2,751 2,797 1.7%
Gross profit Rs m 813 958 17.8%
Depreciation Rs m 78 78 0.4%
Interest Rs m 9 6 -33.4%
Profit before tax Rs m 1,041 1,186 14.0%
Tax Rs m 206 277 34.3%
Profit after tax Rs m 835 910 9.0%
Gross profit margin % 33.4 38.5
Effective tax rate % 19.8 23.3
Net profit margin % 34.3 36.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF

CARE RATING Balance Sheet Analysis

  • The company's current liabilities during FY21 stood at Rs 6 billion as compared to Rs 5 billion in FY20, thereby witnessing an increase of 3.1%.
  • Current assets rose 35% and stood at Rs 11 billion, while fixed assets fell 61% and stood at Rs 1 billion in FY21.
  • Overall, the total assets and liabilities for FY21 stood at Rs 12 billion as against Rs 11 billion during FY20, thereby witnessing a growth of 7%.

CARE RATING Balance Sheet as on March 2021

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Networth Rs m 5,097 5,641 10.7
 
Current Liabilities Rs m 5,406 5,574 3.1
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 10,988 11,751 6.9
 
Current assets Rs m 7,771 10,512 35.3
Fixed Assets Rs m 3,218 1,239 -61.5
Total Assets Rs m 10,988 11,751 6.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



CARE RATING Cash Flow Statement Analysis

  • CARE RATING's cash flow from operating activities (CFO) during FY21 stood at Rs 862 million, an improvement of 27.8% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY21 stood at Rs -380 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY21 stood at Rs -434 million, an improvement of 59% on a YoY basis.
  • Overall, net cash flows for the company during FY21 stood at Rs 48 million from the Rs -128 million net cash flows seen during FY20.

CARE RATING Cash Flow Statement 2020-21

Particulars No. of months 12 12 % Change
Year Ending Mar-20 Mar-21
Cash Flow from Operating Activities Rs m 674 862 27.8%
Cash Flow from Investing Activities Rs m 267 -380 -
Cash Flow from Financing Activities Rs m -1,070 -434 -
Net Cash Flow Rs m -128 48 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for CARE RATING

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 30.9, an improvement from the EPS of Rs 28.3 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 411.3, stands at 13.4 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.2 times, while the price to sales ratio stands at 4.9 times.
  • The company's price to cash flow (P/CF) ratio stood at 13.2 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Sales per share (Unadj.) Rs 82.7 84.3
TTM Earnings per share Rs 28.3 30.9
Diluted earnings per share Rs 28.2 30.7
Price to Cash Flow x 10.7 13.2
TTM P/E ratio x 11.7 13.4
Price / Book Value ratio x 3.6 2.3
Market Cap Rs m 18,494 13,023
Dividends per share (Unadj.) Rs 19.5 17.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for CARE RATING

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.9x during FY21, from 1.4x during FY20. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 193.0x during FY21, from 113.2x during FY20. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 16.1% during FY21, from 16.4% during FY21. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 21.1% during FY21, from 20.6% during FY20. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 7.8% during FY21, from 7.7% during FY20. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Current ratio x 1.4 1.9
Debtors’ Days Days 613 314
Interest coverage x 113.2 193.0
Debt to equity ratio x 0.0 0.0
Return on assets % 7.7 7.8
Return on equity % 16.4 16.1
Return on capital employed % 20.6 21.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how CARE RATING has performed over the last 5 years, please visit here.

CARE RATING Share Price Performance

Over the last one year, CARE RATING share price has moved up from Rs 329.6 to Rs 411.3, registering a gain of Rs 81.7 or around 24.8%.

Overall, the S&P BSE SENSEX is up 74.1% over the year.

(To know more, check out historical annual results for CARE RATING and quarterly results for CARE RATING)

Annual Report FAQs

What is the current share price of CARE RATING?

CARE RATING currently trades at Rs 1,072.9 per share. You can check out the latest share price performance of CARE RATING here...

What was the revenue of CARE RATING in FY21? How does it compare to earlier years?

The revenues of CARE RATING stood at Rs 2,797 m in FY21, which was up 1.7% compared to Rs 2,751 m reported in FY20.

CARE RATING's revenue has fallen from Rs 3,211 m in FY17 to Rs 2,797 m in FY21.

Over the past 5 years, the revenue of CARE RATING has grown at a CAGR of -3.4%.

What was the net profit of CARE RATING in FY21? How does it compare to earlier years?

The net profit of CARE RATING stood at Rs 910 m in FY21, which was up 9.0% compared to Rs 835 m reported in FY20.

This compares to a net profit of Rs 1,381 m in FY19 and a net profit of Rs 1,623 m in FY18.

Over the past 5 years, CARE RATING net profit has grown at a CAGR of -11.4%.

What does the cash flow statement of CARE RATING reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of CARE RATING reveals:

  • Cash flow from operations increased in FY21 and stood at Rs 862 m as compared to Rs 674 m in FY20.
  • Cash flow from investments decreased in FY21 and stood at Rs -380 m as compared to Rs 267 m in FY20.
  • Cash flow from financial activity increased in FY21 and stood at Rs -434 m as compared to Rs -1,070 m in FY20.

Here's the cash flow statement of CARE RATING for the past 5 years.

(Rs m)FY17FY18FY19FY20FY21
From Operations1,1901,3381,086674862
From Investments-220-246826267-380
From Financial Activity-958-987-1,954-1,070-434
Net Cashflow12105-42-12848

What does the Key Ratio analysis of CARE RATING reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of CARE RATING reveals:

  • Operating profit margins witnessed a fall and down at 38.5% in FY21 as against 33.4% in FY20.
  • Net profit margins grew from 34.3% in FY20 to 36.6% in FY21.
  • Debt to Equity ratio for FY21 stood at 0.0 as compared to 0.0 in FY20.

Here's the ratio/financial analysis of CARE RATING for the past 5 years.

 FY17FY18FY19FY20FY21
Operating Profit Margin (%)63.463.454.833.438.5
Net Profit Margin (%)51.448.843.334.336.6
Debt to Equity Ratio (x)0.00.00.00.00.0

Read: Latest Annual Report Analysis of CARE RATING

Equitymaster requests your view! Post a comment on "CARE RATING 2020-21 Annual Report Analysis". Click here!